TARGET in the capital increase of Tes Pharma

Deals | Achievements

TARGET assisted Tes Pharma’s founder, prof. Pellicciari, his partners and the company on M&A, corporate and tax profiles in relation to the capital increase reserved to XGen Venture SGR.
Tes Pharma is an Italian biotech company, based in Perugia, engaged in the research, development, and production of high-value active ingredients for therapeutic use.
TARGET’s M&A team was composed by Fabio Coppola, Teresa Di Lillo and Giacomo Antonini; the tax team by Alfredo Malguzzi and Martino Demaria.